|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Disc Medicine, Inc (IRON) |
|
|
$48.05 0.00 (0.00%) as of 4:30 Thu 9/26
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
29,730,000 |
| Market
Cap: |
1.43(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$26.52 - $75.32 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Gemeni Therapeutics is a clinical-stage precision medicine company developing therapeutic compounds to treat genetically defined, age-related macular degeneration (AMD). Co.'s lead product candidate, GEM103, is a recombinant form of the human complement factor H protein and is designed to address complement hyperactivity and overall dysregulation caused by loss of function mutations thus restoring retinal health in patients with AMD.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
388,891 |
388,891 |
1,041,066 |
| Total Buy Value |
$0 |
$14,000,076 |
$14,000,076 |
$29,000,101 |
| Total People Bought |
0 |
3 |
3 |
4 |
| Total Buy Transactions |
0 |
3 |
3 |
6 |
| Total Shares Sold |
5,359 |
7,718 |
1,816,962 |
3,929,884 |
| Total Sell Value |
$263,201 |
$348,817 |
$108,643,672 |
$210,504,498 |
| Total People Sold |
2 |
2 |
9 |
13 |
| Total Sell Transactions |
5 |
8 |
41 |
60 |
| End Date |
2024-07-21 |
2024-04-19 |
2023-10-20 |
2022-10-20 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  White William Richard |
|
– • – |
2024-10-01 |
4 |
AS |
$49.03 |
$10,312 |
D/D |
(201) |
0 |
|
- |
|
| White William Richard |
|
– • – |
2024-10-01 |
4 |
OE |
$9.86 |
$1,982 |
D/D |
201 |
201 |
|
- |
|
| Savage William Jacob |
Chief Medical Officer |
• – – |
2024-09-16 |
4 |
AS |
$47.41 |
$71,115 |
D/D |
(1,500) |
40,405 |
|
1% |
|
| White William Richard |
|
– • – |
2024-09-03 |
4 |
AS |
$49.43 |
$97,158 |
D/D |
(1,957) |
0 |
|
-5% |
|
| White William Richard |
|
– • – |
2024-09-03 |
4 |
OE |
$2.65 |
$6,635 |
D/D |
1,957 |
1,957 |
|
- |
|
| Savage William Jacob |
Chief Medical Officer |
• – – |
2024-09-03 |
4 |
AS |
$50.59 |
$75,885 |
D/D |
(1,500) |
41,905 |
|
-5% |
|
| White William Richard |
|
– • – |
2024-08-01 |
4 |
AS |
$43.24 |
$8,731 |
D/D |
(201) |
0 |
|
11% |
|
| White William Richard |
|
– • – |
2024-08-01 |
4 |
OE |
$9.86 |
$1,982 |
D/D |
201 |
201 |
|
- |
|
| Quisel John D |
Chief Executive Officer |
• • – |
2024-07-08 |
4 |
OE |
$1.01 |
$3,030 |
D/D |
3,000 |
72,065 |
|
- |
|
| White William Richard |
|
– • – |
2024-07-01 |
4 |
AS |
$45.07 |
$9,253 |
D/D |
(201) |
0 |
|
3% |
|
| White William Richard |
|
– • – |
2024-07-01 |
4 |
OE |
$9.86 |
$1,982 |
D/D |
201 |
201 |
|
- |
|
| Blavatnik Len |
|
– – • |
2024-06-17 |
4 |
A |
$36.00 |
$15,000,012 |
D/D |
416,667 |
3,558,426 |
|
- |
|
| Ashiya Mona |
Director |
– • – |
2024-06-17 |
4 |
B |
$36.00 |
$3,000,024 |
I/I |
83,334 |
235,391 |
2.1 |
13% |
|
| Orbimed Genesis Gp Llc |
Director |
– • – |
2024-06-17 |
4 |
B |
$36.00 |
$3,000,024 |
I/I |
83,334 |
235,391 |
2.1 |
13% |
|
| Bitterman Kevin |
|
– • – |
2024-06-17 |
4 |
B |
$36.00 |
$8,000,028 |
I/I |
222,223 |
420,549 |
0.01 |
13% |
|
| White William Richard |
|
– • – |
2024-06-03 |
4 |
AS |
$35.15 |
$70,608 |
D/D |
(1,957) |
0 |
|
33% |
|
| White William Richard |
|
– • – |
2024-06-03 |
4 |
OE |
$2.65 |
$6,635 |
D/D |
1,957 |
1,957 |
|
- |
|
| White William Richard |
|
– • – |
2024-05-01 |
4 |
AS |
$28.52 |
$5,755 |
D/D |
(201) |
0 |
|
70% |
|
| White William Richard |
|
– • – |
2024-05-01 |
4 |
OE |
$9.86 |
$1,982 |
D/D |
201 |
201 |
|
- |
|
| White William Richard |
|
– • – |
2024-04-11 |
4 |
AS |
$31.79 |
$81,407 |
D/D |
(2,560) |
0 |
|
52% |
|
| White William Richard |
|
– • – |
2024-04-11 |
4 |
OE |
$2.65 |
$12,581 |
D/D |
2,560 |
2,560 |
|
- |
|
| Savage William Jacob |
Chief Medical Officer |
• – – |
2024-04-10 |
4 |
OE |
$2.65 |
$57,956 |
D/D |
21,870 |
43,405 |
|
- |
|
| Bitterman Kevin |
|
– • – |
2024-03-05 |
4 |
S |
$73.50 |
$1,922,540 |
I/I |
(26,157) |
677,503 |
|
31% |
|
| Stephenson Pamela |
Chief Commercial Officer |
• – – |
2024-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
36,666 |
36,666 |
|
- |
|
| Franchi Jean M. |
Chief Financial Officer |
• – – |
2024-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
36,666 |
36,666 |
|
- |
|
134 Records found
|
|
Page 1 of 6 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
